IVUS
IVUS 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Coronary Artery Disease、Coronary Artery Disease Risk High、Complex Coronary Artery Disease。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
1 项
已进入 III/IV 期
19 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- ECRI bv
- Chonnam National University Hospital
- China National Center for Cardiovascular Diseases
- Samsung Medical Center
- Guillermo Galeote; MD, PhD
- Stanford University
- Korea University Anam Hospital
- Novo Nordisk A/S
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
South Korea、中国、西班牙、美国、奥地利、丹麦、意大利、荷兰、瑞士、Poland、英国、比利时
正在招募患者的 IVUS 研究
Imaging and Physiologic Evaluation of Coronary Artery Disease
不适用招募中South KoreaNCT05124249IVUS-FFR Accuracy for Coronary Stenosis
不适用招募中中国NCT07446023IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
不适用招募中South KoreaNCT05812963Coronary Rotational Atherectomy Elective vs. Bailout in Severely Calcified Lesions and Chronic Renal Failure
不适用招募中西班牙NCT05353946Evaluation of Patients With Non-obstructive Coronary Arteries
不适用招募中美国NCT00823563Korean NIRS-IVUS Multicenter Registry
不适用招募中South KoreaNCT04619355A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
III 期招募中奥地利丹麦意大利荷兰NCT07301034Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction
不适用招募中中国NCT06154395Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
不适用招募中South KoreaNCT06954714Lower Silesian Orbital Atherectomy Registry (LOAR)
不适用招募中PolandNCT06451146Identification of Lesion Characteristics in Coronary Plaques Using Multimodality Intravascular Imaging and Novel Photon-counting CT in Stable Angina
不适用招募中英国NCT07864025The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
不适用招募中美国NCT07479433IVUS CHIP China Registry
不适用招募中中国NCT06274645IVUS-guided DES Implantation in Coronary Calcification
不适用招募中中国NCT05800002Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
不适用招募中South KoreaNCT02792075Impact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion
不适用招募中中国NCT07853261Clinical Implications of Three-vessel Ultrasonic Flow Ratio Measurement in Patients With Coronary Artery Disease
不适用招募中中国NCT06822894Feasibility Study of the FARAFLEX Mapping and PFA System
不适用招募中比利时CroatiaCzechia意大利NCT06510556STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)
不适用招募中South KoreaNCT05438121The Lower Silesia Shockwave Registry
不适用招募中PolandNCT05916898Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
不适用招募中美国NCT04399941ROVUS Asia Registry (Evaluate Safety and Effectiveness of Rotational Atherectomy and Intravascular Ultrasound for Heavily Calcified Coronary Lesion)
不适用招募中日本SingaporeNCT04742478THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
不适用招募中美国法国德国GreeceNCT06559891Vascular Complications After Kidney Transplantation
不适用招募中丹麦NCT07531966
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。